A four-active scalp solution adding azelaic acid's direct tyrosinase-independent DHT inhibition and anti-inflammatory activity to the MFK foundation, delivering an additional pathway of androgenetic hair loss suppression for patients with elevated scalp inflammation or inadequate response to finasteride alone.

2-Day UPS